Industry: Medical Devices & Consumables
Published Date: 2026-01-09
Pages: 139 Pages
Report ld: 5625916
Request Sample
Customized Report
Aortic and Peripheral Vascular Interventional Devices Market Size(US$)

CAGR 2026-2032
12.3%
Market Size,2032
USD 178,410
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Aortic and Peripheral Vascular Interventional Devices was estimated to be worth US$ 80080 million in 2025 and is projected to reach US$ 178410 million, growing at a CAGR of 12.3% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Aortic and Peripheral Vascular Interventional Devices cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
The North American market for Aortic and Peripheral Vascular Interventional Devices was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Aortic and Peripheral Vascular Interventional Devices was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Aortic and Peripheral Vascular Interventional Devices was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Aortic and Peripheral Vascular Interventional Devices market include Boston Scientific, Abbott, Medtronic, Terumo, Nipro, B. Braun, Cook Medical, MicroPort, Lepu Medical, Jiwei Medical, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Aortic and Peripheral Vascular Interventional Devices, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Aortic and Peripheral Vascular Interventional Devices market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Aortic and Peripheral Vascular Interventional Devices.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Aortic and Peripheral Vascular Interventional Devices manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Aortic and Peripheral Vascular Interventional Devices sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Aortic and Peripheral Vascular Interventional Devices sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Aortic and Peripheral Vascular Interventional Devices Product Introduction
1.2 Global Aortic and Peripheral Vascular Interventional Devices Market Size Forecast
1.2.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Value (2021–2032)
1.2.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume (2021–2032)
1.2.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Price (2021–2032)
1.3 Aortic and Peripheral Vascular Interventional Devices Market Trends & Drivers
1.3.1 Aortic and Peripheral Vascular Interventional Devices Industry Trends
1.3.2 Aortic and Peripheral Vascular Interventional Devices Market Drivers & Opportunities
1.3.3 Aortic and Peripheral Vascular Interventional Devices Market Challenges
1.3.4 Aortic and Peripheral Vascular Interventional Devices Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Aortic and Peripheral Vascular Interventional Devices Players Revenue Ranking (2025)
2.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Company (2021–2026)
2.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume Ranking of Players (2025)
2.4 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Company (2021–2026)
2.5 Global Aortic and Peripheral Vascular Interventional Devices Average Price by Company (2021–2026)
2.6 Key Manufacturers Aortic and Peripheral Vascular Interventional Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Aortic and Peripheral Vascular Interventional Devices Product Offerings
2.8 Key Manufacturers Start of Mass Production of Aortic and Peripheral Vascular Interventional Devices
2.9 Aortic and Peripheral Vascular Interventional Devices Market Competitive Analysis
2.9.1 Aortic and Peripheral Vascular Interventional Devices Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Aortic and Peripheral Vascular Interventional Devices Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Aortic and Peripheral Vascular Interventional Devices revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Aortic and Peripheral Vascular Interventional Devices Market Classification
3.1 Introduction by Type
3.1.1 Aorta
3.1.2 Peripheral Blood Vessels
3.1.3 Coronary Blood Vessels
3.1.4 Cerebral Blood Vessels
3.1.5 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Type
3.1.5.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Value, by Type (2021–2032)
3.1.5.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Value, by Type (%), 2021–2032
3.1.6 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Type
3.1.6.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume, by Type (2021–2032)
3.1.6.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume, by Type (%), 2021–2032
3.1.7 Global Aortic and Peripheral Vascular Interventional Devices Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Application
4.2.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Value, by Application (2021–2032)
4.2.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Value, by Application (%), 2021–2032
4.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Application
4.3.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume, by Application (2021–2032)
4.3.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume, by Application (%), 2021–2032
4.4 Global Aortic and Peripheral Vascular Interventional Devices Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Region
5.1.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Region (2021–2026)
5.1.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Region (2027–2032)
5.1.4 Global Aortic and Peripheral Vascular Interventional Devices Sales Value by Region (%), 2021–2032
5.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Region
5.2.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Region (2021–2026)
5.2.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Region (2027–2032)
5.2.4 Global Aortic and Peripheral Vascular Interventional Devices Sales Volume by Region (%), 2021–2032
5.3 Global Aortic and Peripheral Vascular Interventional Devices Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
5.4.2 North America Aortic and Peripheral Vascular Interventional Devices Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
5.5.2 Europe Aortic and Peripheral Vascular Interventional Devices Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
5.6.2 Asia Pacific Aortic and Peripheral Vascular Interventional Devices Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
5.7.2 South America Aortic and Peripheral Vascular Interventional Devices Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
5.8.2 Middle East & Africa Aortic and Peripheral Vascular Interventional Devices Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Aortic and Peripheral Vascular Interventional Devices Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Aortic and Peripheral Vascular Interventional Devices Sales Value and Sales Volume
6.2.1 Key Countries/Regions Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.2.2 Key Countries/Regions Aortic and Peripheral Vascular Interventional Devices Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.3.2 United States Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Aortic and Peripheral Vascular Interventional Devices Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.4.2 Europe Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Aortic and Peripheral Vascular Interventional Devices Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.5.2 China Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (%), 2025 vs 2032
6.5.3 China Aortic and Peripheral Vascular Interventional Devices Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.6.2 Japan Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Aortic and Peripheral Vascular Interventional Devices Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.7.2 South Korea Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Aortic and Peripheral Vascular Interventional Devices Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.8.2 Southeast Asia Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Aortic and Peripheral Vascular Interventional Devices Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Aortic and Peripheral Vascular Interventional Devices Sales Value, 2021–2032
6.9.2 India Aortic and Peripheral Vascular Interventional Devices Sales Value by Type (%), 2025 vs 2032
6.9.3 India Aortic and Peripheral Vascular Interventional Devices Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.1.5 Boston Scientific Recent Developments
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Abbott Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.2.5 Abbott Recent Developments
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Medtronic Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.3.5 Medtronic Recent Developments
7.4 Terumo
7.4.1 Terumo Company Information
7.4.2 Terumo Introduction and Business Overview
7.4.3 Terumo Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Terumo Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.4.5 Terumo Recent Developments
7.5 Nipro
7.5.1 Nipro Company Information
7.5.2 Nipro Introduction and Business Overview
7.5.3 Nipro Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Nipro Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.5.5 Nipro Recent Developments
7.6 B. Braun
7.6.1 B. Braun Company Information
7.6.2 B. Braun Introduction and Business Overview
7.6.3 B. Braun Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 B. Braun Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.6.5 B. Braun Recent Developments
7.7 Cook Medical
7.7.1 Cook Medical Company Information
7.7.2 Cook Medical Introduction and Business Overview
7.7.3 Cook Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Cook Medical Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.7.5 Cook Medical Recent Developments
7.8 MicroPort
7.8.1 MicroPort Company Information
7.8.2 MicroPort Introduction and Business Overview
7.8.3 MicroPort Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 MicroPort Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.8.5 MicroPort Recent Developments
7.9 Lepu Medical
7.9.1 Lepu Medical Company Information
7.9.2 Lepu Medical Introduction and Business Overview
7.9.3 Lepu Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Lepu Medical Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.9.5 Lepu Medical Recent Developments
7.10 Jiwei Medical
7.10.1 Jiwei Medical Company Information
7.10.2 Jiwei Medical Introduction and Business Overview
7.10.3 Jiwei Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Jiwei Medical Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.10.5 Jiwei Medical Recent Developments
7.11 Asahi Intecc
7.11.1 Asahi Intecc Company Information
7.11.2 Asahi Intecc Introduction and Business Overview
7.11.3 Asahi Intecc Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Asahi Intecc Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.11.5 Asahi Intecc Recent Developments
7.12 Kaneka
7.12.1 Kaneka Company Information
7.12.2 Kaneka Introduction and Business Overview
7.12.3 Kaneka Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Kaneka Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.12.5 Kaneka Recent Developments
7.13 Sino Medical
7.13.1 Sino Medical Company Information
7.13.2 Sino Medical Introduction and Business Overview
7.13.3 Sino Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Sino Medical Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.13.5 Sino Medical Recent Developments
7.14 LifeTech
7.14.1 LifeTech Company Information
7.14.2 LifeTech Introduction and Business Overview
7.14.3 LifeTech Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 LifeTech Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.14.5 LifeTech Recent Developments
7.15 Gore
7.15.1 Gore Company Information
7.15.2 Gore Introduction and Business Overview
7.15.3 Gore Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Gore Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.15.5 Gore Recent Developments
7.16 Cordis
7.16.1 Cordis Company Information
7.16.2 Cordis Introduction and Business Overview
7.16.3 Cordis Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Cordis Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.16.5 Cordis Recent Developments
7.17 Acotec Scientific Holdings
7.17.1 Acotec Scientific Holdings Company Information
7.17.2 Acotec Scientific Holdings Introduction and Business Overview
7.17.3 Acotec Scientific Holdings Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Acotec Scientific Holdings Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.17.5 Acotec Scientific Holdings Recent Developments
7.18 Zylox-Tonbridge Medical Technology
7.18.1 Zylox-Tonbridge Medical Technology Company Information
7.18.2 Zylox-Tonbridge Medical Technology Introduction and Business Overview
7.18.3 Zylox-Tonbridge Medical Technology Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Zylox-Tonbridge Medical Technology Aortic and Peripheral Vascular Interventional Devices Product Offerings
7.18.5 Zylox-Tonbridge Medical Technology Recent Developments
8 Industry Chain Analysis
8.1 Aortic and Peripheral Vascular Interventional Devices Industrial Chain
8.2 Aortic and Peripheral Vascular Interventional Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Aortic and Peripheral Vascular Interventional Devices Sales Model
8.5.2 Sales Channels
8.5.3 Aortic and Peripheral Vascular Interventional Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 80080 million in 2025 to US$ 178410 million by 2032, at a CAGR of 12.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 173
USD 4900.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 80080 million in 2025 and is forecast to reach a readjusted size of US$ 178410 million by 2032 with a CAGR of 12.3% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 101
USD 4250.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market was valued at US$ 80080 million in 2025 and is anticipated to reach US$ 178410 million by 2032, at a CAGR of 12.3% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 129
USD 2900.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 72100 million in 2024 to US$ 160620 million by 2031, at a CAGR of 12.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 180
USD 4900.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 108
USD 4250.00
(Single User License)
The global market for Aortic and Peripheral Vascular Interventional Devices was estimated to be worth US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 136
USD 3950.00
(Single User License)
The global market for Aortic and Peripheral Vascular Interventional Devices was valued at US$ 72100 million in the year 2024 and is projected to reach a revised size of US$ 160620 million by 2031, growing at a CAGR of 12.3% during the forecast period.
Published Date: 2025-03-10
Pages: 106
USD 2900.00
(Single User License)
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published Date: 2024-10-10
Pages: 175
USD 4900.00
(Single User License)
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published Date: 2024-10-10
Pages: 147
USD 4350.00
(Single User License)
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published Date: 2024-10-10
Pages: 103
USD 2900.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 80080 million in 2025 to US$ 178410 million by 2032, at a CAGR of 12.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 173
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 80080 million in 2025 and is forecast to reach a readjusted size of US$ 178410 million by 2032 with a CAGR of 12.3% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 101
The global Aortic and Peripheral Vascular Interventional Devices market was valued at US$ 80080 million in 2025 and is anticipated to reach US$ 178410 million by 2032, at a CAGR of 12.3% from 2026 to 2032.
Published: 2026-01-09
Pages: 129
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 72100 million in 2024 to US$ 160620 million by 2031, at a CAGR of 12.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 180
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 108
The global market for Aortic and Peripheral Vascular Interventional Devices was estimated to be worth US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 136
The global market for Aortic and Peripheral Vascular Interventional Devices was valued at US$ 72100 million in the year 2024 and is projected to reach a revised size of US$ 160620 million by 2031, growing at a CAGR of 12.3% during the forecast period.
Published: 2025-03-10
Pages: 106
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published: 2024-10-10
Pages: 175
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published: 2024-10-10
Pages: 147
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published: 2024-10-10
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now